An experimental drug from Nektar Therapeutics was able to shrink tumors and reduce a cancer biomarker in women with advanced ovarian cancer in a mid-stage study.
Author: Global Cancer Consortium
A disease that affects a significant number of Americans, that requires extensive and often frustrating lifestyle modifications, and that has no approved pharmaceutical treatment: It’s an enticing opportunity for drug companies.
Though selected in order to give a platform to lesser recognized businesses, the companies presenting demonstrated the vast diversity of the healthcare and life science spaces.
As President Obama prepares to release his U.S. AIDS strategy, at least one pharmaceutical company is readying a crucial clinical trial of its vaccine against HIV/AIDS.
Celgene has acquired Abraxis BioScience in a cash-and-stock deal valued at $2.9 billion, reports FierceBiotech.
OneMedPlace announced that it will showcase to investors and entrepreneurs the newest and most promising new medical technologies in the region.
The company is a medical devices company that has developed a novel technology for site directed, electronic driven radiation therapy for the treatment of cancer. The company’s product delivers high doses of radiation directly to tumors using a miniaturized electronic X-ray source, rather than radioactive chemicals. Using this type of electronic radiation source increases the safety of radiation therapy since the radiation can be turned on and off, unlike chemical radiation sources that continuously emit radiation. Furthermore, the company’s product delivers radiation to tumor sites directly, thereby preserving healthy surrounding tissue. The company’s technology enables physicians to more readily treat…
The company is a medical device company that has developed a cutting edge catheter-based drug delivery technology that enables the delivery of drugs to highly specific sites in patients. The company’s technology enables the set-in positioning of catheters at the site of interest, and then infuses drugs into the blood vessels that are leading directly to the tissue that is being targeted. The products ability to precisely target and isolate where in the body drugs are delivered enables physicians to significantly increase drug concentrations all the while reducing systemic side effects, a major treatment goal in cancer where chemotherapy damages…